Delivery Systems for Tuberculosis Prevention and Treatment

Zusatztext

<p>Provides a review of novel pharmaceutical approaches for Tuberculosis drugs</p><ul><li>Presents a novel perspective on tuberculosis prevention and treatment</li><li>Considers the nature of disease, immunological responses, vaccine and drug delivery, disposition and response</li><li>Multidisciplinary appeal, with contributions from microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics, chemical and mechanical engineering</li></ul>

Autorenportrait

<p><b>Anthony J. Hickey</b>, Distinguished Fellow (appointed June 2012), is a Program Director in Inhaled Therapeutics in the Center for Aerosol and Nanomaterials Engineering at the Research Triangle Institute, North Carolina, USA.<br />Dr Hickey has more than 30 years of academic and research experience in pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design, and device development. Since joining RTI in 2011, he has conducted research related to pulmonary drug and vaccine delivery for tuberculosis treatment and therapy.<br />Additionally, Dr. Hickey is an adjunct professor of biomedical engineering at the University of North Carolina at Chapel Hill School of Medicine, emeritus professor of molecular pharmaceutics at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy, and founder and president of Cirrus Pharmaceuticals, Inc.</p>

Weitere Details